PL1933843T3 - Wykorzystanie walerianianu estradiolu lub estradiolu w kombinacji z dienogestem do doustnej terapii czynnościowego krwawienia macicznego w formie doustnej antykoncepcji - Google Patents

Wykorzystanie walerianianu estradiolu lub estradiolu w kombinacji z dienogestem do doustnej terapii czynnościowego krwawienia macicznego w formie doustnej antykoncepcji

Info

Publication number: PL1933843T3
Authority: PL; Poland
Prior art keywords: estradiol; oral; dienogest; uterine bleeding; combined
Prior art date: 2005-10-13

Application number

PL06806225T

Other languages

English (en)

Inventor

Susan Zeun

Pol Boudes

Jan Endrikat

Angelo Secci

Holger Zimmermann

Original Assignee

Bayer Ip Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-13

Filing date

2006-10-12

Publication date

2011-06-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35811580&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1933843(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-10-12 Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh

2011-06-30 Publication of PL1933843T3 publication Critical patent/PL1933843T3/pl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

PL06806225T 2005-10-13 2006-10-12 Wykorzystanie walerianianu estradiolu lub estradiolu w kombinacji z dienogestem do doustnej terapii czynnościowego krwawienia macicznego w formie doustnej antykoncepcji PL1933843T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP05022324A EP1787649B1 (de)	2005-10-13	2005-10-13	Verwendung von Estradiolvalerat in Kombination mit Dienogest zur oralen Therapie der dysfunktionellen uterinen Blutung in Einheit mit einer oralen Kontrazeption
EP06806225A EP1933843B1 (de)	2005-10-13	2006-10-12	Verwendung von estradiolvalerat oder estradiol in kombination mit dienogest zur oralen therapie der dysfunktionellen uterinen blutung in einheit mit einer oralen kontrazeption
PCT/EP2006/009867 WO2007042296A1 (de)	2005-10-13	2006-10-12	Verwendung von estradiolvalerat oder estradiol in kombination mit dienogest zur oralen therapie der dysfunktionellen uterinen blutung in einheit mit einer oralen kontrazeption

Publications (1)

Publication Number	Publication Date
PL1933843T3 true PL1933843T3 (pl)	2011-06-30

Family

ID=35811580

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL05022324T PL1787649T3 (pl)	2005-10-13	2005-10-13	Zastosowanie walerianianu estradiolu w połączeniu z dienogestem do doustnej terapii dysfunkcyjnego krawienia macicznego w całości z doustną antykoncepcją
PL06806225T PL1933843T3 (pl)	2005-10-13	2006-10-12	Wykorzystanie walerianianu estradiolu lub estradiolu w kombinacji z dienogestem do doustnej terapii czynnościowego krwawienia macicznego w formie doustnej antykoncepcji

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL05022324T PL1787649T3 (pl)	2005-10-13	2005-10-13	Zastosowanie walerianianu estradiolu w połączeniu z dienogestem do doustnej terapii dysfunkcyjnego krawienia macicznego w całości z doustną antykoncepcją

Country Status (22)

Country	Link
EP (2)	EP1787649B1 (pl)
JP (2)	JP5735200B2 (pl)
KR (2)	KR101218872B1 (pl)
CN (1)	CN101312733A (pl)
AR (1)	AR056694A1 (pl)
AT (2)	ATE424828T1 (pl)
CA (1)	CA2623024C (pl)
CL (1)	CL2011000283A1 (pl)
CY (2)	CY1110321T1 (pl)
DE (2)	DE502005006837D1 (pl)
DK (2)	DK1787649T3 (pl)
DO (1)	DOP2006000221A (pl)
ES (2)	ES2322479T3 (pl)
HR (1)	HRP20090256T1 (pl)
ME (1)	ME01056B (pl)
PE (2)	PE20100090A1 (pl)
PL (2)	PL1787649T3 (pl)
PT (2)	PT1787649E (pl)
SI (2)	SI1787649T1 (pl)
TW (2)	TWI328453B (pl)
UY (1)	UY29861A1 (pl)
WO (1)	WO2007042296A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102004019743B4 (de)	2004-04-20	2008-11-27	Bayer Schering Pharma Aktiengesellschaft	Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
DK1787649T3 (da) *	2005-10-13	2009-06-02	Bayer Schering Pharma Ag	Anvendelse af estradiovalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blöding i enhed med en oral kontraception
US8153616B2 (en)	2005-10-17	2012-04-10	Bayer Pharma Aktiengesellschaft	Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de)	2006-10-20	2008-06-11	Bayer Schering Pharma Aktiengesellschaft	Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4429374C1 (de) *	1994-08-12	1996-02-01	Jenapharm Gmbh	Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19540253C2 (de) *	1995-10-28	1998-06-04	Jenapharm Gmbh	Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
ATE249222T1 (de) *	1996-07-26	2003-09-15	Wyeth Corp	Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten
US6251956B1 (en)	1998-08-20	2001-06-26	Ortho Pharmaceutical Corporation	Combination progestin oral contraceptive regimen
EP1462106A1 (en) *	2003-03-28	2004-09-29	Pantarhei Bioscience B.V.	Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
DE102004019743B4 (de) *	2004-04-20	2008-11-27	Bayer Schering Pharma Aktiengesellschaft	Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
DK1787649T3 (da) *	2005-10-13	2009-06-02	Bayer Schering Pharma Ag	Anvendelse af estradiovalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blöding i enhed med en oral kontraception

2005
- 2005-10-13 DK DK05022324T patent/DK1787649T3/da active
- 2005-10-13 AT AT05022324T patent/ATE424828T1/de active
- 2005-10-13 SI SI200530672T patent/SI1787649T1/sl unknown
- 2005-10-13 EP EP05022324A patent/EP1787649B1/de not_active Revoked
- 2005-10-13 DE DE502005006837T patent/DE502005006837D1/de not_active Expired - Lifetime
- 2005-10-13 ES ES05022324T patent/ES2322479T3/es not_active Expired - Lifetime
- 2005-10-13 PT PT05022324T patent/PT1787649E/pt unknown
- 2005-10-13 ME MEP-2009-171A patent/ME01056B/me unknown
- 2005-10-13 PL PL05022324T patent/PL1787649T3/pl unknown
2006
- 2006-10-12 CN CNA2006800381810A patent/CN101312733A/zh active Pending
- 2006-10-12 ES ES06806225T patent/ES2360302T3/es active Active
- 2006-10-12 KR KR1020107014574A patent/KR101218872B1/ko active Active
- 2006-10-12 CA CA2623024A patent/CA2623024C/en active Active
- 2006-10-12 PE PE2009001256A patent/PE20100090A1/es not_active Application Discontinuation
- 2006-10-12 JP JP2008534936A patent/JP5735200B2/ja active Active
- 2006-10-12 WO PCT/EP2006/009867 patent/WO2007042296A1/de not_active Ceased
- 2006-10-12 PL PL06806225T patent/PL1933843T3/pl unknown
- 2006-10-12 PT PT06806225T patent/PT1933843E/pt unknown
- 2006-10-12 KR KR1020087011203A patent/KR20080065651A/ko not_active Ceased
- 2006-10-12 DE DE502006008853T patent/DE502006008853D1/de active Active
- 2006-10-12 DK DK06806225.6T patent/DK1933843T3/da active
- 2006-10-12 PE PE2006001241A patent/PE20070555A1/es not_active Application Discontinuation
- 2006-10-12 AT AT06806225T patent/ATE497387T1/de active
- 2006-10-12 EP EP06806225A patent/EP1933843B1/de active Active
- 2006-10-12 TW TW095137564A patent/TWI328453B/zh active
- 2006-10-12 SI SI200630991T patent/SI1933843T1/sl unknown
- 2006-10-13 AR ARP060104489A patent/AR056694A1/es not_active Application Discontinuation
- 2006-10-13 DO DO2006000221A patent/DOP2006000221A/es unknown
- 2006-10-13 UY UY29861A patent/UY29861A1/es not_active Application Discontinuation
2007
- 2007-01-09 TW TW096100872A patent/TW200829255A/zh unknown
2009
- 2009-05-05 HR HR20090256T patent/HRP20090256T1/xx unknown
- 2009-06-11 CY CY20091100621T patent/CY1110321T1/el unknown
2011
- 2011-02-10 CL CL2011000283A patent/CL2011000283A1/es unknown
- 2011-05-02 CY CY20111100422T patent/CY1111406T1/el unknown
2012
- 2012-11-19 JP JP2012253067A patent/JP2013047269A/ja active Pending

Also Published As

Publication number	Publication date
TW200731977A (en)	2007-09-01
PT1933843E (pt)	2011-04-29
TW200829255A (en)	2008-07-16
CA2623024C (en)	2012-03-06
PL1787649T3 (pl)	2009-08-31
DK1787649T3 (da)	2009-06-02
EP1933843B1 (de)	2011-02-02
PE20070555A1 (es)	2007-07-12
JP5735200B2 (ja)	2015-06-17
CN101312733A (zh)	2008-11-26
TWI328453B (en)	2010-08-11
DE502005006837D1 (de)	2009-04-23
ATE497387T1 (de)	2011-02-15
WO2007042296A1 (de)	2007-04-19
ATE424828T1 (de)	2009-03-15
KR20100082389A (ko)	2010-07-16
JP2009511526A (ja)	2009-03-19
ME01056B (me)	2012-10-20
CA2623024A1 (en)	2007-04-19
JP2013047269A (ja)	2013-03-07
DK1933843T3 (da)	2011-04-18
CY1111406T1 (el)	2015-08-05
DE502006008853D1 (de)	2011-03-17
ES2322479T3 (es)	2009-06-22
UY29861A1 (es)	2007-05-31
EP1787649A1 (de)	2007-05-23
ES2360302T3 (es)	2011-06-02
SI1933843T1 (sl)	2011-06-30
PE20100090A1 (es)	2010-03-12
KR20080065651A (ko)	2008-07-14
HRP20090256T1 (en)	2009-06-30
PT1787649E (pt)	2009-05-08
CL2011000283A1 (es)	2011-07-08
EP1787649B1 (de)	2009-03-11
SI1787649T1 (sl)	2009-08-31
KR101218872B1 (ko)	2013-01-07
EP1933843A1 (de)	2008-06-25
DOP2006000221A (es)	2007-08-31
AR056694A1 (es)	2007-10-17
CY1110321T1 (el)	2015-01-14

Similar Documents

Publication	Publication Date	Title
IL198200A0 (en)	2009-12-24	Use of estradiol valerate or 17??-estradiol in combination with dienogest for oral therapy for maintaining and/or increasing the female libido
IL187982A0 (en)	2008-03-20	Human placental collagen compositions, processes for their preparation, methods of their use and kits comprising the compositions
IL199151A (en)	2017-01-31	Pyrimidine derivatives, their pharmaceutical preparations, their use in cancer treatment and their kits
AP2965A (en)	2014-09-30	Therapeutic compositions and the use thereof
AP2490A (en)	2012-10-04	Therapeutic compositions and the use thereof
IL213795A (en)	2013-05-30	An immunogenic preparation containing at least two different saccharides and a compound containing the aforementioned immunogenic preparation
GB2453011B (en)	2010-06-23	Antifolate agent compositions in the treatment of cancer
SI2069342T1 (sl)	2010-09-30	Derivati aril fenil imidazo a piridinov njihova priprava in njihova terapevtska uporaba
IL192053A (en)	2014-01-30	2-Admentiluria derivatives as selective inhibitors of 1hsd-β11 and their use in drug preparation
GB0427145D0 (en)	2005-01-12	Compositions for use in surgery
IL199265A (en)	2015-06-30	Oxindol derivatives are converted and used to make a drug
IL180899A0 (en)	2007-07-04	Pharmaceutical composition comprising drospirenone and ethynylestradiol
ZA201001085B (en)	2011-04-28	Indol-2-one derivatives disubstituted in the 3-position,preparation thereof and therapeutic use thereof
IL180797A0 (en)	2007-06-03	Amino-tropane derivatives, preparation thereof and therapeutic use thereof
EP1874800A4 (en)	2009-11-18	DIAGNOSTIC AND THERAPEUTIC AGENTS
IL190519A0 (en)	2008-11-03	6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
IL198481A0 (en)	2010-02-17	Pyrrole derivatives, preparation use of the same in therapy
LT1858481T (lt)	2019-07-10	Oftalmologinės kompozicijos ir jų panaudojimas
SI1933843T1 (sl)	2011-06-30	Uporaba estradiol valerata ali estradiola v kombinaciji z dienogestom za oralno terapijo disfunkcijske maternične krvavitve skupaj z oralno kontracepcijo
ZA200900035B (en)	2010-03-31	Prophylactic or therapeutic agent for viral disease
IL202474A0 (en)	2010-06-30	1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof
TH0601005011A (th)	2016-03-23	การใช้เอสตราไดออลวาเลอเรตหรือเอสตราไดออลร่วมกับไดอีโนเจสต์สำหรับการรักษาโดยให้ทางปากในการตกเลือดในมดลูกแบบที่ทำงานผิดปกติ ร่วมกับยาคุมกำเนิดสำหรับให้ทางปาก
IL187419A0 (en)	2008-02-09	Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents
GB0503632D0 (en)	2005-03-30	Time/temperature indicators, their preparation and use
ZA200704806B (en)	2008-09-25	Novel betulin derivatives, preparation thereof and use thereof